United States · FDA National Drug Code directory
Cetirizine Hydrochloride (Hives Relief)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-813_9e202d7d-9a96-448b-bd71-bd7234b9e2a2
- Product NDC
- 58602-813
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150805
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 CARTON (58602-813-04) · 58602-813-04
- 1 BOTTLE in 1 CARTON (58602-813-09) / 30 TABLET in 1 BOTTLE · 58602-813-09
- 1 BOTTLE in 1 CARTON (58602-813-17) / 45 TABLET in 1 BOTTLE · 58602-813-17
- 1 BOTTLE in 1 CARTON (58602-813-23) / 120 TABLET in 1 BOTTLE · 58602-813-23
- 1 BOTTLE in 1 CARTON (58602-813-39) / 365 TABLET in 1 BOTTLE · 58602-813-39
- 1000 TABLET in 1 BOTTLE (58602-813-41) · 58602-813-41
- 10 TABLET in 1 BLISTER PACK (58602-813-83) · 58602-813-83
- 75 TABLET in 1 PACKAGE, COMBINATION (58602-813-99) · 58602-813-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →